The global Drug Eluting Balloons (DEB) market size was valued at US$ 571.3 million in 2023. With growing demand in downstream market, the Drug Eluting Balloons (DEB) is forecast to a readjusted size of US$ 1393.9 million by 2030 with a CAGR of 13.6% during review period.
The research report highlights the growth potential of the global Drug Eluting Balloons (DEB) market. Drug Eluting Balloons (DEB) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug Eluting Balloons (DEB). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug Eluting Balloons (DEB) market.
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells.
Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.
Global Drug Eluting Balloons(DEB) key players include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, etc. Global top 5 manufacturers hold a share over 84%.
Europe is the largest market, with a share about 42%, followed by North America, and Asia-Pacific, both have a share about 52 percent.
In terms of product, Peripheral DEBs is the largest segment, with a share over 57%. And in terms of application, the largest application is Hospital, followed by Catheterization Laboratory, Others.
Key Features:
The report on Drug Eluting Balloons (DEB) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Drug Eluting Balloons (DEB) market. It may include historical data, market segmentation by Type (e.g., Peripheral DEBs, Coronary DEBs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug Eluting Balloons (DEB) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug Eluting Balloons (DEB) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drug Eluting Balloons (DEB) industry. This include advancements in Drug Eluting Balloons (DEB) technology, Drug Eluting Balloons (DEB) new entrants, Drug Eluting Balloons (DEB) new investment, and other innovations that are shaping the future of Drug Eluting Balloons (DEB).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug Eluting Balloons (DEB) market. It includes factors influencing customer ' purchasing decisions, preferences for Drug Eluting Balloons (DEB) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug Eluting Balloons (DEB) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug Eluting Balloons (DEB) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug Eluting Balloons (DEB) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug Eluting Balloons (DEB) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug Eluting Balloons (DEB) market.
Market Segmentation:
Drug Eluting Balloons (DEB) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Peripheral DEBs
Coronary DEBs
Segmentation by application
Catheterization Laboratory
Hospital
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
B. Braun
Medtronic
Boston Scientific
BD
Yinyi
Philips
Eurocor
Aachen Resonance
Biotronic
Key Questions Addressed in this Report
What is the 10-year outlook for the global Drug Eluting Balloons (DEB) market?
What factors are driving Drug Eluting Balloons (DEB) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Eluting Balloons (DEB) market opportunities vary by end market size?
How does Drug Eluting Balloons (DEB) break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Eluting Balloons (DEB) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Drug Eluting Balloons (DEB) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Drug Eluting Balloons (DEB) by Country/Region, 2019, 2023 & 2030
2.2 Drug Eluting Balloons (DEB) Segment by Type
2.2.1 Peripheral DEBs
2.2.2 Coronary DEBs
2.3 Drug Eluting Balloons (DEB) Sales by Type
2.3.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2019-2024)
2.3.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Drug Eluting Balloons (DEB) Sale Price by Type (2019-2024)
2.4 Drug Eluting Balloons (DEB) Segment by Application
2.4.1 Catheterization Laboratory
2.4.2 Hospital
2.4.3 Others
2.5 Drug Eluting Balloons (DEB) Sales by Application
2.5.1 Global Drug Eluting Balloons (DEB) Sale Market Share by Application (2019-2024)
2.5.2 Global Drug Eluting Balloons (DEB) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Drug Eluting Balloons (DEB) Sale Price by Application (2019-2024)
3 Global Drug Eluting Balloons (DEB) by Company
3.1 Global Drug Eluting Balloons (DEB) Breakdown Data by Company
3.1.1 Global Drug Eluting Balloons (DEB) Annual Sales by Company (2019-2024)
3.1.2 Global Drug Eluting Balloons (DEB) Sales Market Share by Company (2019-2024)
3.2 Global Drug Eluting Balloons (DEB) Annual Revenue by Company (2019-2024)
3.2.1 Global Drug Eluting Balloons (DEB) Revenue by Company (2019-2024)
3.2.2 Global Drug Eluting Balloons (DEB) Revenue Market Share by Company (2019-2024)
3.3 Global Drug Eluting Balloons (DEB) Sale Price by Company
3.4 Key Manufacturers Drug Eluting Balloons (DEB) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Balloons (DEB) Product Location Distribution
3.4.2 Players Drug Eluting Balloons (DEB) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Drug Eluting Balloons (DEB) by Geographic Region
4.1 World Historic Drug Eluting Balloons (DEB) Market Size by Geographic Region (2019-2024)
4.1.1 Global Drug Eluting Balloons (DEB) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Drug Eluting Balloons (DEB) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Drug Eluting Balloons (DEB) Market Size by Country/Region (2019-2024)
4.2.1 Global Drug Eluting Balloons (DEB) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Drug Eluting Balloons (DEB) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Drug Eluting Balloons (DEB) Sales Growth
4.4 APAC Drug Eluting Balloons (DEB) Sales Growth
4.5 Europe Drug Eluting Balloons (DEB) Sales Growth
4.6 Middle East & Africa Drug Eluting Balloons (DEB) Sales Growth
5 Americas
5.1 Americas Drug Eluting Balloons (DEB) Sales by Country
5.1.1 Americas Drug Eluting Balloons (DEB) Sales by Country (2019-2024)
5.1.2 Americas Drug Eluting Balloons (DEB) Revenue by Country (2019-2024)
5.2 Americas Drug Eluting Balloons (DEB) Sales by Type
5.3 Americas Drug Eluting Balloons (DEB) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Balloons (DEB) Sales by Region
6.1.1 APAC Drug Eluting Balloons (DEB) Sales by Region (2019-2024)
6.1.2 APAC Drug Eluting Balloons (DEB) Revenue by Region (2019-2024)
6.2 APAC Drug Eluting Balloons (DEB) Sales by Type
6.3 APAC Drug Eluting Balloons (DEB) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Drug Eluting Balloons (DEB) by Country
7.1.1 Europe Drug Eluting Balloons (DEB) Sales by Country (2019-2024)
7.1.2 Europe Drug Eluting Balloons (DEB) Revenue by Country (2019-2024)
7.2 Europe Drug Eluting Balloons (DEB) Sales by Type
7.3 Europe Drug Eluting Balloons (DEB) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Eluting Balloons (DEB) by Country
8.1.1 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Drug Eluting Balloons (DEB) Revenue by Country (2019-2024)
8.2 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Type
8.3 Middle East & Africa Drug Eluting Balloons (DEB) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Balloons (DEB)
10.3 Manufacturing Process Analysis of Drug Eluting Balloons (DEB)
10.4 Industry Chain Structure of Drug Eluting Balloons (DEB)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Balloons (DEB) Distributors
11.3 Drug Eluting Balloons (DEB) Customer
12 World Forecast Review for Drug Eluting Balloons (DEB) by Geographic Region
12.1 Global Drug Eluting Balloons (DEB) Market Size Forecast by Region
12.1.1 Global Drug Eluting Balloons (DEB) Forecast by Region (2025-2030)
12.1.2 Global Drug Eluting Balloons (DEB) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug Eluting Balloons (DEB) Forecast by Type
12.7 Global Drug Eluting Balloons (DEB) Forecast by Application
13 Key Players Analysis
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.1.3 B. Braun Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.2.3 Medtronic Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.3.3 Boston Scientific Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.4.3 BD Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi
13.5.1 Yinyi Company Information
13.5.2 Yinyi Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.5.3 Yinyi Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Yinyi Main Business Overview
13.5.5 Yinyi Latest Developments
13.6 Philips
13.6.1 Philips Company Information
13.6.2 Philips Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.6.3 Philips Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Philips Main Business Overview
13.6.5 Philips Latest Developments
13.7 Eurocor
13.7.1 Eurocor Company Information
13.7.2 Eurocor Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.7.3 Eurocor Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Eurocor Main Business Overview
13.7.5 Eurocor Latest Developments
13.8 Aachen Resonance
13.8.1 Aachen Resonance Company Information
13.8.2 Aachen Resonance Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.8.3 Aachen Resonance Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Aachen Resonance Main Business Overview
13.8.5 Aachen Resonance Latest Developments
13.9 Biotronic
13.9.1 Biotronic Company Information
13.9.2 Biotronic Drug Eluting Balloons (DEB) Product Portfolios and Specifications
13.9.3 Biotronic Drug Eluting Balloons (DEB) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Biotronic Main Business Overview
13.9.5 Biotronic Latest Developments
14 Research Findings and Conclusion
*If Applicable.